国药现代(600420.SH)子公司获得富马酸喹硫平缓释片药品注册证书

Core Viewpoint - China National Pharmaceutical Group Modern (国药现代) announced that its wholly-owned subsidiary, China National Pharmaceutical Group Industrial Co., Ltd. (国药工业), has received the drug registration certificate for Fumaric Acid Quetiapine Extended-Release Tablets from the National Medical Products Administration [1] Group 1 - The Fumaric Acid Quetiapine Extended-Release Tablets are classified as atypical antipsychotic medications [1] - This medication is primarily used for the treatment of schizophrenia and bipolar disorder, helping to stabilize mood, reduce hallucinations, and improve cognitive function [1] - The drug aims to assist patients in regaining normal cognitive and social abilities [1]